AOK Bayern is seeking pharmaceutical companies to enter into non-exclusive discount agreements for the drug Airpiprazol in the form of depot injection suspension (ATC N05AX12). This is not a traditional open procedure but an open-house model, meaning contracts can be signed at any time until July 3,
343 days left to bid. Opened 1 years ago, deadline 3 Jul 2027.
This is not a standard open procedure but an open-house model! The form for the open procedure is used only because there is no form for the open-house model. Contracts made under the open-house model are not subject to procurement law due to the lack of a selection decision. The AOK Bayern intends
This contract opportunity is for reception and security services required by AOK Bayern - Die Gesundheitskasse. Suppliers are invited to provide professional reception services, which may include managing visitor access, handling inquiries, and ensuring a secure environment. The contract is publishe
This announcement by AOK Bayern aims to provide transparency regarding all contracts concluded under the Open House procedure for pharmaceutical discount contracts according to § 130a Abs. 8 SGB V and § 130a Abs. 8c SGB V from 13.07.2025 to 12.08.2025. AOK Bayern intends to enter into non-exclusive
This is not a standard procurement procedure but an open-house model. The form used is for an open procedure only because there is no specific form for the open-house model. Contracts made under this model are not subject to procurement law due to the lack of a selection decision. AOK Bayern intends
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
